![Correction of the Phe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine]()
Correction of the Phe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound GlafenineRobert, R.; Carlile, G. W.; Liao, J.; Balghi, H.; Lesimple, P.; Liu, N.; Kus, B.; Rotin, D.; Wilke, M.; de Jonge, H. R.; Scholte, B. J.; Thomas, D. Y.; Hanrahan, J. W. · Molecular Pharmacology · 2010